These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 37078398)

  • 1. Safety Outcomes of Selective Serotonin Reuptake Inhibitors in Adolescent Attention-Deficit/Hyperactivity Disorder with Comorbid Depression: The ASSURE Study - CORRIGENDUM.
    Kim C; Lee DY; Park J; Yang SJ; Tan EH; Alhambra DP; Lee YH; Lee S; Kim SJ; Lee J; Park RW; Shin Y
    Psychol Med; 2023 Jul; 53(10):4831. PubMed ID: 37078398
    [No Abstract]   [Full Text] [Related]  

  • 2. Safety outcomes of selective serotonin reuptake inhibitors in adolescent attention-deficit/hyperactivity disorder with comorbid depression:
    Kim C; Lee DY; Park J; Yang SJ; Tan EH; Alhambra DP; Lee YH; Lee S; Kim SJ; Lee J; Park RW; Shin Y
    Psychol Med; 2023 Jul; 53(10):4811-4819. PubMed ID: 36803587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of venlafaxine treatment for ADHD in a child.
    Pleak RR; Gormly LJ
    Am J Psychiatry; 1995 Jul; 152(7):1099. PubMed ID: 7793453
    [No Abstract]   [Full Text] [Related]  

  • 4. Analyse this.
    Brower V
    EMBO Rep; 2003 Nov; 4(11):1022-4. PubMed ID: 14593440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical perspectives: combined pharmacotherapy.
    O'Malley KD
    J Am Acad Child Adolesc Psychiatry; 1995 Dec; 34(12):1558-9. PubMed ID: 8543526
    [No Abstract]   [Full Text] [Related]  

  • 6. Fluoxetine monotherapy in attention-deficit/hyperactivity disorder and comorbid non-bipolar mood disorders in children and adolescents.
    Quintana H; Butterbaugh GJ; Purnell W; Layman AK
    Child Psychiatry Hum Dev; 2007 Feb; 37(3):241-53. PubMed ID: 17103304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pharmacotherapy of ADHD in adults with comorbid depression].
    Ohlmeier MD
    Psychiatr Prax; 2007 Sep; 34 Suppl 3():S296-9. PubMed ID: 17786887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of serotonin norepinephrine reuptake inhibitors in the treatment of attention-deficit hyperactivity disorder in pediatrics.
    Park P; Caballero J; Omidian H
    Ann Pharmacother; 2014 Jan; 48(1):86-92. PubMed ID: 24259607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of adult ADHD and comorbid disorders.
    Young JL
    CNS Spectr; 2006 Oct; 11(10 Suppl 11):10-2. PubMed ID: 17712918
    [No Abstract]   [Full Text] [Related]  

  • 10. Attention deficit hyperactivity disorder and non-stimulant medication treatment.
    Finks K
    NASN Sch Nurse; 2012 Mar; 27(2):78-80. PubMed ID: 22567781
    [No Abstract]   [Full Text] [Related]  

  • 11. Sequential pharmacotherapy for children with comorbid attention-deficit/hyperactivity and anxiety disorders.
    Abikoff H; McGough J; Vitiello B; McCracken J; Davies M; Walkup J; Riddle M; Oatis M; Greenhill L; Skrobala A; March J; Gammon P; Robinson J; Lazell R; McMahon DJ; Ritz L;
    J Am Acad Child Adolesc Psychiatry; 2005 May; 44(5):418-27. PubMed ID: 15843763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comorbidity of obsessive-compulsive disorder and attention-deficit/hyperactivity disorder in referred children and adolescents.
    Masi G; Millepiedi S; Mucci M; Bertini N; Pfanner C; Arcangeli F
    Compr Psychiatry; 2006; 47(1):42-7. PubMed ID: 16324901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dystonia as a side effect of nonneuroleptics.
    Chong Y; Harris R; Kim WJ
    J Am Acad Child Adolesc Psychiatry; 1999 Jul; 38(7):793-5. PubMed ID: 10405494
    [No Abstract]   [Full Text] [Related]  

  • 14. Gestational Exposure to Selective Serotonin Reuptake Inhibitors and Offspring Psychiatric Disorders: A National Register-Based Study.
    Malm H; Brown AS; Gissler M; Gyllenberg D; Hinkka-Yli-Salomäki S; McKeague IW; Weissman M; Wickramaratne P; Artama M; Gingrich JA; Sourander A
    J Am Acad Child Adolesc Psychiatry; 2016 May; 55(5):359-66. PubMed ID: 27126849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pregnancy and delivery complications and treatment approach in attention deficit hyperactivity disorder.
    Aktepe E; Ozkorumak E; Tanriöver-Kandil S
    Turk J Pediatr; 2009; 51(5):478-84. PubMed ID: 20112604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment Efficacy of Combined Sertraline and Guanfacine in Comorbid Obsessive-Compulsive Disorder and Attention Deficit/Hyperactivity Disorder: Two Case Studies.
    Taormina SP; Galloway MP; Rosenberg DR
    J Dev Behav Pediatr; 2016; 37(6):491-5. PubMed ID: 27011005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment and treatment of attention deficit hyperactivity disorder in children with comorbid psychiatric illness.
    Waxmonsky J
    Curr Opin Pediatr; 2003 Oct; 15(5):476-82. PubMed ID: 14508296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Associations of Maternal Antidepressant Use During the First Trimester of Pregnancy With Preterm Birth, Small for Gestational Age, Autism Spectrum Disorder, and Attention-Deficit/Hyperactivity Disorder in Offspring.
    Sujan AC; Rickert ME; Öberg AS; Quinn PD; Hernández-Díaz S; Almqvist C; Lichtenstein P; Larsson H; D'Onofrio BM
    JAMA; 2017 Apr; 317(15):1553-1562. PubMed ID: 28418479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enuresis with combined risperidone and SSRI use.
    Took KJ; Buck BJ
    J Am Acad Child Adolesc Psychiatry; 1996 Jul; 35(7):840-1. PubMed ID: 8768340
    [No Abstract]   [Full Text] [Related]  

  • 20. Ssri-induced sexual dysfunction in adolescents.
    Scharko AM; Reiner WG
    J Am Acad Child Adolesc Psychiatry; 2004 Sep; 43(9):1067-8. PubMed ID: 15322407
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.